A pilot study to explore the tolerability and efficacy of bortezomib as part of induction and post-transplant therapy in multiple myeloma.
Phase of Trial: Phase II
Latest Information Update: 20 Jun 2016
At a glance
- Drugs Bortezomib (Primary) ; Dexamethasone; Doxorubicin; Prednisolone; Vincristine
- Indications Multiple myeloma
- Focus Adverse reactions; Therapeutic Use
- Acronyms BIR
- 29 Nov 2012 Status changed from recruiting to completed as reported by Australian New Zealand Clinical Trials Registry record.
- 20 Jan 2009 New trial record.